
Today Show Hosts Discussed GLP-1 Usage
The Today 3rd Hour hosts addressed personal weight loss methods on air during a recent broadcast.

The Today 3rd Hour hosts addressed personal weight loss methods on air during a recent broadcast.
September 24, 2026
Obesity Linked to Worse Outcomes in Hepatitis CasesA new multicenter study found that obesity acts as an independent risk factor for survival and complications in alcohol-associated hepatitis.
September 24, 2026
Bridget Fonda Has Reportedly Lost 100 PoundsThe 62-year-old former actress was recently spotted in Los Angeles following a major transformation.
September 23, 2026
Childhood Obesity Treatment Proven EffectiveA six-year clinical trial showed that family-based care in primary settings improves weight outcomes for children.
September 23, 2026
Wave Life Sciences Launched Obesity Clinical TrialThe Phase 2a trial tests WVE-007 alongside tirzepatide for patients managing obesity and type 2 diabetes.
September 23, 2026
Viking Therapeutics Reported Positive Weight Loss DataThe company released trial results for its dual-agonist drug VK2735, causing shares to surge in value.
September 22, 2026
Experts Recommended GLP-1 Therapy GuidelinesClinicians detailed new strategies for optimizing patient outcomes during GLP-1 weight loss medication use.
September 22, 2026
U.S. News Evaluated GLP-1 Telehealth PlatformsThe inaugural rankings highlight top-rated services for patients seeking FDA-approved weight-loss medications.
September 22, 2026
CPAP Adherence Rose Among GLP-1 PatientsData shows that patients using weight-loss drugs are more likely to stick with sleep apnea therapy.
September 22, 2026
Department of Veterans Affairs Operates MOVE! ProgramThe VA offers weight management support to veterans through nutrition education and physical activity guidance.
September 22, 2026
GLP-1 Drugs Linked to Sleep Disorders in 2026 ReportsNew case studies identified potential associations between common weight loss medications and parasomnias.